GLP-1 drugs for pets could be the next frontier for the blockbuster weight loss and diabetes drugs. By Emily Anthes In just a few short years, new diabetes and weight loss drugs like Ozempic, Wegovy ...

Prediabetes is essentially an intermediate condition between normal blood sugar levels and diabetes. Because it’s considered a significant risk factor for type 2 diabetes, as well as other ...

Diagnosing VTEs typically involves a combination of medical imaging, including ultrasound, computerized tomography angiogram, echocardiogram and blood tests, along with an evaluation by a health care ...

Systemic disruptions in the metabolism of carbohydrates, fats, proteins, and micronutrients cause micro- and macro-vascular damage and impede recovery, which is the driving force behind type 2 ...

Join us as we test out a massive new piece of equipment. We'll give you a first look at the 91-foot Summers land roller in action and show you its full capabilities. Donald Trump issues funding threat ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. In 2024 Stephen Rich and his colleagues ...

Detecting diabetes might soon be as easy as breathing into a device, a new study says. An experimental breath test sorted out type 2 diabetes patients from healthy people, based on their exhalations, ...

SpaceX’s 403-foot Starship was set to lift off Sunday evening from the company’s Starbase facility in South Texas, marking its most ambitious test yet after a string of setbacks. But the launch of ...

Measuring elevated levels of insulin in the blood, called hyperinsulinemia, is a proven way to measure metabolic health and can show the risk of developing future health concerns, including type 2 ...

Tools for assessing proprioceptive deficits, which include joint position sense and postural control tests, are best used in combination to optimize results. One of the many topics covered at the 2025 ...

Dipa Kamdar does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...